Case

MYDAWA

SDGS
https://impactfund.dk/wp-content/themes/impactfund/assets/dist/img/sdg-icons/good_health.svg https://impactfund.dk/wp-content/themes/impactfund/assets/dist/img/sdg-icons/gender_equality.svg
Facts
Year 2024
Sector Healthcare
Fund IFU
Current investment DKK 63.5m
Regions Africa

MYDAWA, one of East Africa’s leading pharmacy and telehealth providers, is opening 30 new pharmacies in Uganda, 10 new pharmacies in Kenya as well as expanding their online pharmacy platform, aiming to reach 8.4 million patients annually by 2032. Impact Fund Denmark’s investment supports the ambitious expansion plan to address the issue of low access to quality healthcare in Uganda and Kenya.

In Uganda, two thirds of all pharmacies are located in the capital of Kampala, but only 10 per cent of the population is living there. Consequently, the majority of people in Uganda has limited access to quality medicines and healthcare.

In Kenya, authorities have tried to implement control guidelines for pharmacies’ authorization of healthcare products, but uncertified products are still widely spread.

40 new pharmacies – healthcare for 8.4 million patients annually

The investment enables MYDAWA to open 30 new pharmacies in Uganda, of which around 15 will be located outside of Kampala. This will improve access to healthcare for the many people living in the peri-urban regions outside the capital.

Additionally, the investment will enable MYDAWA to open 10 physical pharmacies and expand their online pharmacy capacity in Kenya. This will contribute to addressing Kenya’s challenge with widespread uncertified healthcare products, as the online pharmacy is available for all Kenyan patients, and MYDAWA’s online products are certified and of high quality.

With the significant expansion and opening of 40 new pharmacies, MYDAWA aims to provide healthcare to 8.4 million patients annually across Uganda and Kenya in 2032.